| 1. | What is the principal role of dermoscopy? |
| A. | Detecting and diagnosing of cutaneous malignancies |
| B. | Diagnosing infectious diseases |
| C. | Diagnosing vascular diseases |
| D. | Diagnosing bullous pemphigoid |
| E. | Diagnosing pemphigus vulgaris |
| 2. | Which of the follows is NOT an advantage of dermoscope-guided excisional biopsy? |
| A. | Higher magnification |
| B. | Underlying tissues visible |
| C. | Continuous flow of high-quality images |
| D. | A wide range of scopes is available |
| E. | Shorter time for the procedure |
| 3. | Which one of the following is considered to be a specific passive category of cancer immunotherapy? |
| A. | Bacillus Calmette-Guerin (BCG) |
| B. | Oncogenic virus vaccines |
| C. | Lymphokine-activated killer cells |
| D. | Immune checkpoint inhibitors |
| E. | Tumour-infiltrating lymphocytes |
| 4. | Concerning the management of the side effects of immune checkpoint inhibitors, which one of the following statements is NOT TRUE: |
| A. | Most toxicities of immune checkpoint inhibitors are mild and can be managed easily with a course of steroids. |
| B. | The aim of management is always to identify and address any side effects before it becomes severe. |
| C. | All side effects of immune checkpoint inhibitors require emergent management and hospitalization in order to avoid delay in treatment. |
| D. | The primary care physician had a role in the management of side effects of immune checkpoint inhibitors. |
| E. | The primary care physician needs to be vigilant in ruling out autoimmune side effects when dealing with any illness in a cancer patient who has been given checkpoint inhibitors. |
| 5. | Which of the following disease entities does not belong to atypical parkinsonism? |
| A. | Multiple System Atrophy (MSA) |
| B. | Progressive Supranuclear Palsy (PSP) |
| C. | Corticobasal Degeneration (CBD) |
| D. | Motor Neuron Disease (MND) |
| E. | Vascular parkinsonism |
| 6. | The most accurate diagnostic imaging for idiopathic Parkinson’s disease is: |
| A. | CT brain |
| B. | MRI brain |
| C. | PET with Parkinson’s disease protocol |
| D. | X-ray |
| E. | Ultrasound |